The penetrance of the MYOC p.Gln368Ter variant was 7.6% in people with glaucoma (based on self-report or International Classification of Diseases) in the UKB, but the penetrance of glaucoma was 56.1% in the ANZRAG.18 This evidence concerns the gene MYOC and glaucoma.